Omeros Gross Margin 2010-2025 | OMER

Current and historical gross margin for Omeros (OMER) over the last 10 years. The current gross profit margin for Omeros as of March 31, 2025 is %.
Omeros Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2020-06-30 $0.07B $0.07B 97.06%
2020-03-31 $0.08B $0.08B 98.77%
2019-09-30 $0.10B $0.10B 100.00%
2019-06-30 $0.08B $0.08B 100.00%
2019-03-31 $0.05B $0.05B 100.00%
2018-12-31 $0.03B $0.03B 96.77%
2018-09-30 $0.02B $0.02B 91.30%
2018-06-30 $0.04B $0.04B 92.50%
2018-03-31 $0.06B $0.05B 94.55%
2017-12-31 $0.07B $0.06B 96.92%
2017-09-30 $0.06B $0.06B 98.44%
2017-06-30 $0.05B $0.05B 100.00%
2017-03-31 $0.05B $0.05B 100.00%
2016-12-31 $0.04B $0.04B 100.00%
2016-09-30 $0.04B $0.03B 97.14%
2016-06-30 $0.03B $0.03B 96.30%
2016-03-31 $0.02B $0.02B 95.00%
2015-12-31 $0.01B $0.01B 92.31%
2015-09-30 $0.01B $0.01B 100.00%
2015-06-30 $0.00B $0.00B 100.00%
2015-03-31 $0.00B 0 0.00%
2014-12-31 $0.00B 0 0.00%
2014-09-30 $0.00B 0 0.00%
2014-06-30 $0.00B 0 0.00%
2014-03-31 $0.00B 0 0.00%
2013-12-31 $0.00B $0.00B 100.00%
2013-09-30 $0.00B $0.00B 100.00%
2013-06-30 $0.00B $0.00B 100.00%
2013-03-31 $0.01B $0.01B 100.00%
2012-12-31 $0.01B $0.01B 100.00%
2012-09-30 $0.01B $0.01B 100.00%
2012-06-30 $0.01B $0.01B 100.00%
2012-03-31 $0.00B $0.00B 100.00%
2011-12-31 $0.00B $0.00B 100.00%
2011-09-30 $0.00B $0.00B 100.00%
2011-06-30 $0.00B $0.00B 100.00%
2011-03-31 $0.00B $0.00B 100.00%
2010-12-31 $0.00B $0.00B 100.00%
2010-09-30 $0.00B 0 0.00%
2010-06-30 $0.00B 0 0.00%
2010-03-31 $0.00B 0 0.00%
2009-12-31 $0.00B 0 0.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.224B $0.000B
Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. Omeros' most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM) platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Omeros has four ongoing PharmacoSurgery(TM) clinical development programs, and its lead product candidate, OMS103HP, is being evaluated in Phase 3 clinical trials for use during arthroscopic surgery to improve postoperative joint function and reduce postoperative pain. Omeros is also building a diverse pipeline of preclinical programs targeting inflammation and central nervous system disorders.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $218.924B 25.68
Boston Scientific (BSX) United States $159.425B 38.08
Stryker (SYK) United States $153.031B 32.00
EssilorLuxottica (ESLOY) France $136.054B 0.00
Medtronic (MDT) Ireland $118.007B 16.73
Lonza Group Ag (LZAGY) Switzerland $50.909B 0.00
Haleon (HLN) United Kingdom $43.800B 25.00
ResMed (RMD) United States $40.084B 30.11
GE HealthCare Technologies (GEHC) United States $35.372B 16.79
Agilent Technologies (A) United States $33.937B 22.12
Terumo (TRUMY) Japan $25.318B 32.88
Koninklijke Philips (PHG) Netherlands $24.891B 17.47
Insulet (PODD) United States $20.174B 79.19
Zimmer Biomet Holdings (ZBH) United States $19.257B 12.37
Baxter (BAX) United States $14.656B 10.94
Smith & Nephew SNATS (SNN) United Kingdom $13.945B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $6.996B 24.34
Lantheus Holdings (LNTH) United States $5.072B 12.79
Perrigo (PRGO) Ireland $3.866B 9.80
Prestige Consumer Healthcare (PBH) United States $3.792B 16.94
Haemonetics (HAE) United States $3.582B 16.32
Envista Holdings (NVST) United States $3.517B 29.23
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.175B 23.41
LeMaitre Vascular (LMAT) United States $1.856B 41.49
QuidelOrtho (QDEL) United States $1.799B 12.37
AtriCure (ATRC) United States $1.526B 0.00
Acuren (TIC) United States $1.435B 0.00
AdaptHealth (AHCO) United States $1.301B 13.20
Green Thumb Industries (GTBIF) United States $1.217B 27.38
Phibro Animal Health (PAHC) United States $1.208B 15.44
Neogen (NEOG) United States $1.098B 14.06
BioLife Solutions (BLFS) United States $1.074B 0.00
InMode (INMD) Israel $0.944B 9.51
Kestra Medical Technologies (KMTS) United States $0.859B 0.00
Curaleaf Holdings (CURLF) Canada $0.838B 0.00
Tilray Brands (TLRY) Canada $0.741B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.667B 0.00
Owens & Minor (OMI) United States $0.637B 5.28
Valneva SE (VALN) France $0.622B 0.00
Evolus (EOLS) United States $0.618B 0.00
CeriBell (CBLL) United States $0.569B 0.00
ZimVie (ZIMV) United States $0.523B 23.77
Surmodics (SRDX) United States $0.464B 0.00
SNDL (SNDL) Canada $0.420B 0.00
VAREX IMAGING (VREX) United States $0.317B 11.65
Sanuwave Health (SNWV) United States $0.315B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.314B 0.00
Capricor Therapeutics (CAPR) United States $0.312B 0.00
Cresco Labs (CRLBF) United States $0.298B 0.00
Quanterix (QTRX) United States $0.284B 0.00
Cerus (CERS) United States $0.277B 0.00
Aurora Cannabis (ACB) Canada $0.274B 81.33
Viemed Healthcare (VMD) United States $0.255B 21.53
OraSure Technologies (OSUR) United States $0.247B 0.00
Sanara MedTech (SMTI) United States $0.243B 0.00
Canopy Growth (CGC) Canada $0.240B 0.00
Biote (BTMD) United States $0.232B 6.52
Brainsway (BWAY) Israel $0.225B 59.45
Verano Holdings (VRNOF) United States $0.217B 0.00
Organigram Global (OGI) Canada $0.208B 0.00
High Tide (HITI) Canada $0.196B 0.00
Utah Medical Products (UTMD) United States $0.189B 15.39
TriSalus Life Sciences (TLSI) United States $0.178B 0.00
Exagen (XGN) United States $0.156B 0.00
Vireo Growth (VREOF) United States $0.151B 0.00
FitLife Brands (FTLF) United States $0.127B 15.65
TerrAscend (TSNDF) Canada $0.116B 0.00
MacroGenics (MGNX) United States $0.114B 0.00
Jin Medical (ZJYL) China $0.110B 0.00
Safety Shot (SHOT) United States $0.105B 0.00
Fonar (FONR) United States $0.101B 12.98
Quipt Home Medical (QIPT) United States $0.097B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.094B 0.00
Jushi Holdings (JUSHF) United States $0.087B 0.00
Apyx Medical (APYX) United States $0.086B 0.00
Veru (VERU) United States $0.086B 0.00
Zynex (ZYXI) United States $0.076B 0.00
Agape ATP (ATPC) $0.074B 0.00
InterCure (INCR) Israel $0.070B 0.00
Cytosorbents (CTSO) United States $0.064B 0.00
ImmuCell (ICCC) United States $0.063B 0.00
United-Guardian (UG) United States $0.044B 15.21
Modular Medical (MODD) United States $0.039B 0.00
Rockwell Medical (RMTI) United States $0.038B 0.00
Nephros (NEPH) United States $0.037B 50.43
Allurion Technologies (ALUR) United States $0.024B 0.00
INLIF (INLF) $0.015B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Senestech (SNES) United States $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
IM Cannabis (IMCC) Canada $0.012B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00